Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Ask an expert: How can I reduce my risk of developing skin cancer?

Ask an expert: How can I reduce my risk of developing skin cancer?

Stories May 16, 2023 3 minutes

Your melanoma prevention strategy partly depends on your family history and previous sun exposure.

As the weather heats up, so too do the damaging effects of the sun’s rays. May is Skin Cancer Awareness Month — a time to check in on your skin health and protect you and your family from harmful ultraviolet (UV) radiation. Vancouver Coastal Health Research Institute researcher Dr. Tim Lee sheds light on who is at greater risk of developing skin cancer, also called melanoma, as well as the latest screening approaches.

Q: I have noticed more dark spots on my skin as I age. Does this put me at greater risk of developing skin cancer?
A:
As we age — particularly once we pass the age of 50 — we may develop sun spots that usually occur on areas of the body that receive more sun exposure, such as the back and face. Use the acronym ‘ABCDE’ to remember the warning signs of melanoma: 

  • Asymmetry — one half is noticeably bigger than the other.
  • Border — the mole has uneven edges that might be blurry, jagged or notched.
  • Colour — a mole with different shades of tan, brown or black, or moles with grey, blue, pink, red or white are a warning sign to get checked out by a physician. 
  • Diameter — a mole that measures more than six millimetres across.
  • Evolving — the mole seems to be changing or becomes irritated, itchy or gives you a burning or tingling sensation. 

If unsure, you should always discuss concerns about specific spots with your family physician. 

Q: If melanoma runs in my family, should I get screened more often? 
A:
People who have a higher risk of developing melanoma due to a hereditary predisposition or medical condition — such as a weakened immune system due to an organ transplant or condition such as HIV/AIDS — should receive a skin cancer screening from a physician every three months to one year. Individuals at higher risk of skin cancer should also regularly perform a self-examination alone or with a family member or friend. 

Q: How is melanoma diagnosed? 
A:
Melanoma is usually fairly easy to spot. Often, a patient or their family member will notice a suspicious freckle or mole and book an appointment with a physician or receive a referral to see a dermatologist. During the appointment, a doctor or dermatologist will use a dermoscope, which is a small, hand-held device that provides a magnified view of the skin. The clinician may then order a skin biopsy to confirm whether the lesion is cancerous. 

Our skin is more prone to sun damage as we age. Be vigilant and seek medical advice if you notice any suspicious spots or moles on your body.

Q: What are some of the latest advances in diagnostic technology? 
A:
There is a lot of research underway right now to improve melanoma diagnostics, including using a common phone camera and artificial intelligence (AI) computer technology to identify whether a patient has a suspicious spot that could well be melanoma. There is also a seven-point checklist for melanoma identification that is being adapted using an AI screening tool. Other AI tools can read patient skin lesion images and return similar images of skin lesions from other patients. However, none of these technologies are currently approved for clinical practice. 

Q: Where can I find more science-based information and resources?
A:
Always visit your doctor or dermatologist for more information if you have any concerns about your skin health. I would also recommend that people visit HealthLinkBC and the Canadian Dermatology Association websites for useful resources on skin cancer awareness, screening and prevention.

Dr. Tim Lee is a professor in the Department of Dermatology and Skin Science; an associate member of the Biomedical Engineering Program; and an associate member of the School of Population and Public Health at the University of British Columbia. He is also a researcher with the VCHRI Skin Research Program. Read his latest study: Polarization memory rate as a metric to differentiate benign and malignant tissues.

 

Researchers

Tim Lee

Related Articles

Facing the facts: Suture materials and scar prominence post-surgery

Ask an expert: Do I need to wear sunscreen in the winter?

The invisible lightness of healing

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Skin Research Program

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy